SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-19-205598
Filing Date
2019-07-29
Accepted
2019-07-29 17:08:21
Documents
2
Group Members
CARL D. SODERSTROMCLAY M. HEIGHTEN, M.D.GILBERT G. GARCIA IIGREEN PARK & GOLF VENTURES II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d783933dsc13d.htm SC 13D 122414
2 EX-99.1 d783933dex991.htm EX-99.1 5558
  Complete submission text file 0001193125-19-205598.txt   129751
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Subject) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88731 | Film No.: 19982054
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5910 N. CENTRAL EXPY SUITE 1400 DALLAS TX 75206
Business Address 5910 N. CENTRAL EXPY SUITE 1400 DALLAS TX 75206 2149571026
Salarius 4-18 Investment, LLC (Filed by) CIK: 0001782732 (see all company filings)

IRS No.: 825163342 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D